Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution

Drug and Alcohol Dependence

Volumn 82, Issue 3, 2006, Pages 250-257

  Lejeune, Claude ^a   Simmat Durand, Laurence ^b   Gourarier, Laurent ^c   Aubisson, Sandrine ^b  

^a HÔPITAL LOUIS MOURIER   (France)

^b CNRS   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Addiction and pregnancy; High dose buprenorphine; Maintenance treatments; Methadone; Neonatal abstinence syndrome

Indexed keywords

BUPRENORPHINE; METHADONE; MORPHINE; OPIATE;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; EPIDURAL ANESTHESIA; FEMALE; FOSTER CARE; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; METHADONE TREATMENT; MULTICENTER STUDY; NEONATAL WITHDRAWAL SYNDROME; NEWBORN CARE; OBSERVATIONAL STUDY; OPIATE ADDICTION; PREGNANT WOMAN; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; PROGNOSIS; SAMPLE SIZE; SCORING SYSTEM; TREATMENT OUTCOME; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ADULT; BUPRENORPHINE; FEMALE; HIV SEROPOSITIVITY; HUMANS; INFANT CARE; INFANT, NEWBORN; METHADONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PARITY; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 33646490547     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.10.001     Document Type: Article

References (36)

1. American Academy of Pediatrics, 1998. Committee on Drugs. Neonatal drug withdrawal. Pediatrics 101, 1079-1088.
2. Bays J. Substance abuse and child abuse: impact of addiction on the child. Pediatr. Clin. North Am. 37 (1990) 881-904
3. Berghella V., Lim P.J., Hill M.K., Cherpes J., Chennat J., and Kaltenbach K. Maternal methadone dose and neonatal withdrawal. Am. J. Obstet. Gynecol. 189 (2003) 312-317
4. Brown H.L., Britton K.A., Mahaffey D., Brizendine E., Hiett A.K., and Turnquest M.A. Methadone maintenance in pregnancy: a reappraisal. Am. J. Obstet. Gynecol. 179 (1998) 459-463
5. Dashe J.S., Sheffield J.S., Olscher D.A., Todd S.J., Jackson G.L., and Wendel G.D. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet. Gynecol. 100 (2002) 1244-1249
6. Davis S.K. Chemical dependency in women: a description of its effects and outcome on adequate parenting. J. Subst. Abuse Treat. 7 (1990) 225-232
7. Doberczak T.M., Kandall S.R., and Friedman P. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet. Gynecol. 81 (1993) 936-940
8. Fisher G., Etzersdorfer P., Eder H., Jagsch R., Langer M., and Weninger M. Buprenorphine maintenance in pregnant opiate addicts. Eur. Addict. Res. 4 Suppl. 1 (1998) 32-36
9. Fisher G., Johnson R.E., Eder H., Jagsch R., Peternell A., Weninger M., Langer M., and Aschauer H.N. Treatment of opioid-dependant pregnant women with buprenorphine. Addiction 2 (2000) 239-244
10. Floch-Tudal C., Simonpoli A.M., Montamat S., Couettoux M.P., Crenn-Hebert C., and Lejeune C. Syndrome de sevrage néonatal chez des jumeaux d'une mère sous traitement de substitution par la méthadone. Ann. Méd. Interne. (Paris) 151 Suppl. B (2000) B30-B33
11. Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res. Monogr. 167 (1997) 17-36
12. Hulse G.K., Milne E., English D.R., and Holman C.D. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 92 (1997) 1571-1579
13. Jernite M., Viville B., Escande B., Brettes J.P., and Messer J. Grossesse et buprénorphine. À propos de 24 cas. Arch. Pédiatr. 6 (1999) 1179-1185
14. Johnson R.E., Hendree E.J., Jasinski D.R., Svikis D.S., Haug N.A., Jansson L.M., Kissin W.B., Alpan G., Lantz M.E., Cone E.J., Wilkins D.G., Golden A.S., Huggins G.R., and Lester B.M. Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 63 (2001) 97-103
15. Johnson R.E., Jones H.E., and Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 70 Suppl. 2 (2003) S87-S101
16. Jones H.E., Johnson R.E., Jasinski D.R., O'Grady K.E., Chisholm C.A., Choo R.E., Crocetti M., Dudas R., Harrow C., Huestis M.A., Jansson L.M., Lantz M., Lester B.M., and Milio L. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 79 (2005) 1-10
17. Kaltenbach K.A. Effects of in-utero opiate exposure: new paradigms for old questions. Drug Alcohol Depend. 36 (1994) 83-87
18. Kandall S.R. Treatment strategies for drug-exposed neonates. Clin. Perinatol. 26 (1999) 231-243
19. Kandall S.R., Doberczak T.M., Jantunen M., and Stein J. The methadone-maintained pregnancy. Clin. Perinatol. 26 (1999) 173-183
20. Kintz P., and Marquet P. Buprenorphine therapy of opiate addiction (2000), Humana Press, Totowa, New Jersey
21. Lacroix I., Berrebi A., Chaumerliac C., Lapeyre-Mestre M., Montastruc J.L., and Damase-Michel C. Buprenorphine in pregnant opioid-dependant women: first result of a prospective study. Addiction 99 (2004) 209-214
22. Lejeune C., Floch-Tudal C., Montamat S., Crenn-Hebert C., and Simonpoli A.M. Prise en charge des femmes enceintes toxicomanes et de leurs enfants. Arch. Pédiatr. 4 (1997) 263-270
23. Lejeune C., Ropert J.C., Montamat S., Floch-Tudal C., Mazy F., Wijkhuisen N., and Froment H. Devenir médico-social de 59 nouveau-nés de mère toxicomane. J. Gynécol. Obstet. Biol. Reprod. 26 (1997) 395-404
24. Lejeune C., Aubisson S., Simmat-Durand L., Cneude F., Piquet M., Gourarier L., et al., Groupe d'Études Grossesse et Addictions. Syndromes de sevrage des nouveau-nés de mères substituées par la méthadone ou la buprénorphine haut-dosage. Étude multicentrique prospective de 246 cas. Ann. Méd. Interne (Paris) 152 Suppl. 7 (2001) 2S21-2S27
25. Lejeune, C., Simmat-Durand, L., Aubisson, S., Gourarier, L., Piquet, M., 2003. Grossesse et substitution. Enquête sur les femmes enceintes substituées à la méthadone ou à la buprénorphine haut-dosage et caractéristiques de leurs nouveau-nés. Paris, OFDT, 142 p. http://www.ofdt.fr/.
26. Lipsitz P.J. A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy. Clin. Pediatr. 14 (1975) 592-594
27. ®) de la dépendance aux opiacés chez la femme enceinte. In: 26è Journées Nationales de la Société Française de Médecine Périnatale, Abstract book, Brest.
28. Randal T. Intensive prenatal care may deliver healthy babies to pregnant drug abusers. JAMA 265 (1991) 2773-2774
29. Regan D.O., Ehrlich S.M., and Finnegan L.P. Infants of drug addicts: at risk for child abuse, neglect, and placement in foster care. Neurotoxicol. Teratol. 9 (1987) 315-319
30. Robins L.M., and Mills J.L. Effect of in utero exposure to street drugs. Am. J. Public Health 83 Suppl. (1993) 1-32
31. Schindler S.D., Eder H., Ortner R., Rohrmeister K., Langer M., and Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 98 (2003) 103-110
32. Sutton L.R., and Hinderliter S.A. Diazepam abuse in pregnant women on methadone maintenance. Implications for the neonate. Clin. Pediatr. 29 (1990) 108-111
33. Thirion X., Barrau K., Micallef J., Haramburu F., Lowenstein W., and Sanmarco J.L. Traitements de substitution de la dépendance aux opiacés dans les centres de soins: le programme OPPIDUM des Centres d'Evaluation et d'Information sur la Pharmacodépendance. Ann. Med. Interne 151 Suppl. A (2000) A10-A17
34. Tracqui A., Kintz P., and Ludes B. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J. Anal. Toxicol. 22 (1998) 430-434
35. Ward J., Hall W., and Mattick R.P. Role of maintenance treatment in opioid dependence. Lancet 353 (1999) 221-226
36. Wilbourne P.L., Dorato V., Miller W., and Curet L.B. Benzodiazepine and methadone use is associated with longer neonatal withdrawal in poly-substance exposed infants. Am. J. Obstet. Gynecol. 182 1 Pt 2 (2000) S177 (Abstract 572)